Molecular Diagnostics
Biomarkers Revealed for Cognitive Impairment in PD
Biomarkers have been identified that could predict the cognitive impairment typical of Parkinson's Disease (PD), a neurodegenerative disease that affects about half a million people in the USA, with approximately 50,000 people receive a PD diagnosis every year. More...31 May 2017
Untethered Proteins Could Help Diagnose MKD
Mevalonate Kinase Deficiency (MKD), also known as HIDS (hyper IgD syndrome), is a rare genetic condition that affects approximately 200 individuals worldwide. It is a spectrum of disease, with complications that range from mild to severe. MKD is one of more than 8,000 known rare and genetic conditions, which, although individually uncommon, collectively affect up to 10% of the population. More...30 May 2017
Haptoglobin Genotyping Test Enables Key Diabetes Treatment
A breakthrough ELISA kit, based on the Haptoglobin 2-2 (Hp 2-2) protein marker, can identify diabetes patients at higher risk of developing lethal cardiovascular disease or renal failure, thereby enabling them to take Vitamin E, a nutritional supplement shown to be of great benefit to them but posing harm to the remaining non HP 2-2 diabetic population. A CE mark application for the test is currently in progress, with FDA certification planned for the US market. More...29 May 2017
Recurrent Mutation Linked to Childhood Blindness
Researchers have identified a genetic mutation that contributes to the sight loss that occurs in children with ocular coloboma, a developmental defect that causes part of the eye to be missing at birth. The findings shed light on its causes and help explain how genes contribute to development of the eye. More...29 May 2017
Alzheimer’s Disease Progression Predicted by Gene Mutation
Alzheimer's disease is the most common form of dementia in older adults. It is a degenerative condition, characterized by a steady loss of memory and a reduced ability to carry out daily activities. Today, an estimated five million people in the USA are living with the disease. More...25 May 2017
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Blood Glucose Test Strip
AutoSense Test
New
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
In Other News
Pathogens Help Diagnose Fatty Liver Disease
Gene Sequencing Reveals Mutations in Endometriosis
Molecular Test Predicts Blood Cancer Patient Survival
Solvent Interaction Analysis of PSA Reduces Need for Biopsies
Elevated Levels of Beta-2 Microglobulin Linked to Increased Stroke Risk
Low Levels of Protein Linked to Cognitive Decline
Test Predicts Benefit of Targeted Cancer Treatments
Genomic Duplication Responsible for Rare Skin Disease
Typhoid Fever Victims Present Unique Metabolomic Profile
Child Biomarkers Linked to BD Parents
Immune Response Differentiates Malaria from Other Infections
POC Test Advances Hepatitis C Diagnosis
Genes Should Be Screened for Stem Cell Transplants
Genetics Are Key to Lowering Bone Fracture Risk
Novel Fluorescent Technique Detects Early Stage Glaucoma
Low Levels of 1-Asparaginase Predict Cancer Recurrence
Multigene Test Extends Life Expectancy for Cancer Patients
Bordetella Direct Test Receives FDA Clearance
Bacterial Pathogens Panel Receives CE Marking
Methods Assessed for Detecting Asymptomatic Malaria
Newborn Screening for CMV Remains Controversial
Multiplex Molecular Assays for Respiratory Viruses Evaluated
Panel of Gut Bacteria Diagnostic for Colorectal Cancer
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.